Weight Loss Injections and Thyroid Conditions: What You Need to Know Before Starting

The biggest misconception: a thyroid condition doesn't automatically rule out weight loss injections

The most common thing people assume is that any thyroid diagnosis puts weight loss injections off the table entirely. That isn't accurate. The contraindication that applies to both Mounjaro (tirzepatide) and Wegovy (semaglutide) is specific: a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2. These are rare conditions. The far more common thyroid diagnoses (hypothyroidism (underactive thyroid), managed Hashimoto's thyroiditis, or a history of hyperthyroidism that has since been treated) do not carry the same restriction.

This distinction matters because millions of people in the UK live with hypothyroidism and take levothyroxine daily. If you want to understand how hypothyroidism interacts with weight loss injections, the picture is more nuanced than a simple yes or no. What it does mean is that your prescriber needs the full picture: your current thyroid function test results, your medication, and whether your thyroid is stable. Our guide for thyroid patients considering weight loss injections sets out the practical questions your prescriber will likely explore.

The SmPC (prescribing information) for both medicines, published on the electronic Medicines Compendium, lists the exact contraindications clearly. If you're unsure which category applies to you, that uncertainty is itself the reason to have a clinical conversation before starting.

What we know, what's uncertain, and what the evidence actually covers

Animal studies with GLP-1 medicines showed thyroid C-cell changes at very high doses, and this observation is why the MTC/MEN2 contraindication exists. The clinical significance in humans at therapeutic doses remains an active area of surveillance, and neither the MHRA nor NHS guidance currently extends the restriction beyond that specific personal or family history. The NHS medicines information for tirzepatide reflects this: the contraindication is named precisely, not applied broadly to all thyroid conditions.

Where genuine uncertainty remains is around thyroid function tests during treatment. Weight loss itself can alter TSH levels, and some people find that losing significant weight changes how well their levothyroxine dose is calibrated. There isn't strong prospective evidence on whether GLP-1 medicines independently affect thyroid hormone levels beyond the effect of weight loss, but it is a reason why thyroid monitoring during treatment is sensible practice, something to discuss with your GP or specialist endocrinologist, not only your weight-loss prescriber.

If your thyroid condition is managed by a specialist or is currently unstable, sharing that context openly matters. The broader picture of weight loss injections and thyroid issues covers conditions like Hashimoto's and Graves' disease in more depth if one of those is your specific situation.

Thyroid cancer history: the one situation where caution is firm

This page would be incomplete without addressing thyroid cancer directly, because it is the situation where prescribing guidance is unambiguous. A personal history of medullary thyroid carcinoma, or a family history of it, means GLP-1 receptor agonists are contraindicated, not a matter of clinical discretion, but a listed contraindication in the prescribing information. The same applies to MEN2. If you have had MTC, or a first-degree relative has, weight loss injections of this class are not appropriate for you.

Papillary and follicular thyroid cancers are a different matter. These are by far the most common forms of thyroid cancer in the UK. There is no specific contraindication covering them in the SmPCs for Mounjaro or Wegovy, but anyone with a cancer history should be having this conversation with their oncologist or endocrinologist, not solely with a weight-loss service. Our separate page on weight loss injections and thyroid cancer explores this in more detail. A prescriber at a service like ours will always ask about cancer history, and if there's any ambiguity, the right answer is to involve your specialist team first.

Storing your pen correctly doesn't resolve clinical uncertainty, but it's part of managing treatment well: keep it refrigerated between 2°C and 8°C, and check the Patient Information Leaflet for how long it can sit on the bathroom shelf or in a bag before use, it isn't indefinite.

How to approach this if you have a thyroid condition and want to start

Start with honesty in your consultation. Whether your thyroid diagnosis is recent or long-standing, your prescriber needs to know: the diagnosis, how it's currently managed, and whether it's stable. At nume, a GPhC-registered Independent Prescriber reads every consultation personally, your answers go to a clinician, not processed by software. You can explore what that process looks like on our page on how to get weight loss injections.

If you're on levothyroxine and your thyroid function is well controlled, many people in exactly that situation do use Mounjaro or Wegovy, but approval depends on the clinical review of your specific circumstances. If your thyroid is unstable, or you've recently had a thyroid condition diagnosed and aren't yet optimised, the right step is usually to get that sorted first and then return to the conversation about weight management.

Anyone with MTC, MEN2 in the family, or an active or complex thyroid cancer history should discuss weight management options with their specialist team before approaching any weight-loss service. For everyone else with a thyroid condition, the process is: get your thyroid stable, be transparent in your consultation, and let a prescriber make an informed decision. Our dedicated page on weight loss injections with an underactive thyroid covers the hypothyroidism-specific questions in more depth.

If you're ready to start that conversation, our prescribers are available seven days a week. Start your free consultation and let a clinician review your full picture before any treatment is dispensed.